Compare ARK Genomic Revolution ETF (ARKG) vs iShares iBoxx $ High Yield Corporate Bond ETF (HYG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs iShares iBoxx $ High Yield Corporate Bond ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while iShares iBoxx $ High Yield Corporate Bond ETF trades at $79.78. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, iShares iBoxx $ High Yield Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | HYG | |
|---|---|---|
Sector | Sector/Thematic | Fixed Income |
52-Week High | $43.57 | $81.32 |
52-Week Low | $23.09 | $78.72 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
HYG (iShares iBoxx High Yield Corporate Bond ETF) trades at $79.71, down 0.05% with a bearish technical signal from moving averages. The ETF faces pressure from elevated put volume and broader bond market uncertainty as investors weigh potential Federal Reserve rate hikes. Recent dividend payments of $0.37-$0.42 per share provide income support, but technical indicators show weak momentum with RSI readings in neutral territory.
High-yield bond ETFs face headwinds from rising rate expectations and inflation concerns, though demand for yield remains strong. The bearish technical setup suggests near-term pressure, while institutional bearish positioning indicates cautious sentiment. Income-focused investors may find value in the dividend yield, but rate sensitivity remains a key risk factor.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About iShares iBoxx $ High Yield Corporate Bond ETF
HYG is the world's largest high-yield bond ETF, tracking the Markit iBoxx USD Liquid High Yield Index. It provides liquid exposure to non-investment grade corporate debt, with 2026 top holdings including Cloud Software Group and Medline.
Read more on HYG →
